$18.15
At close: Apr 11, 5:07 PM EDT
$18.16
0.010.06%
Pre-Market: Apr 11, 5:07 PM EDT
Comments
Loading...
ArriVent BioPharma (AVBP) Forecast
NewsEarningsArriVent BioPharma (AVBP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
ArriVent BioPharma Stock Price, Quotes and Forecasts | NASDAQ:AVBP | Benzinga
Explore ArriVent BioPharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AVBP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ArriVent BioPharma (AVBP) stock?
You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.
Who are ArriVent BioPharma (AVBP) competitors?
Other companies in ArriVent BioPharma’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for ArriVent BioPharma (AVBP) stock?
ArriVent BioPharma has a consensus price target of $38.43.
What is the current price for ArriVent BioPharma (AVBP)?
The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $18.16 last updated April 11, 2025 at 5:07 PM EDT.
Does ArriVent BioPharma (AVBP) pay a dividend?
There are no upcoming dividends for ArriVent BioPharma.
When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?
ArriVent BioPharma’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is ArriVent BioPharma (AVBP) going to split?
There is no upcoming split for ArriVent BioPharma.
What sector and industry does ArriVent BioPharma (AVBP) operate in?
ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.